Fig. 4From: Soluble neprilysin and long-term clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cohort studyComparison of outcomes between soluble neprilysin level higher and lower group according to subgroups. a All-cause death and (b) the major cardiovascular eventsBack to article page